These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

560 related articles for article (PubMed ID: 16624028)

  • 1. [Metformin hydrochloride ameliorates adiponectin levels and insulin sensitivity in adolescents with metabolic syndrome].
    Liang L; Fu JF; Zou CC; Hong F; Wang CL; Wang XM
    Zhonghua Er Ke Za Zhi; 2006 Feb; 44(2):118-21. PubMed ID: 16624028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention.
    Fu JF; Liang L; Zou CC; Hong F; Wang CL; Wang XM; Zhao ZY
    Int J Obes (Lond); 2007 Jan; 31(1):15-22. PubMed ID: 16953257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adiponectin and insulin resistance in childhood obesity.
    Panagopoulou P; Galli-Tsinopoulou A; Fleva A; Pavlitou-Tsiontsi E; Vavatsi-Christaki N; Nousia-Arvanitakis S
    J Pediatr Gastroenterol Nutr; 2008 Sep; 47(3):356-62. PubMed ID: 18728534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between serum adiponectin, tumor necrosis factor-alpha, leptin levels and insulin sensitivity in childhood and adolescent obesity: adiponectin is a marker of metabolic syndrome.
    Alikaşifoğlu A; Gönç N; Özön ZA; Sen Y; Kandemir N
    J Clin Res Pediatr Endocrinol; 2009; 1(5):233-9. PubMed ID: 21274300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective Evaluation of Metformin and/or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome.
    Stagi S; Ricci F; Bianconi M; Sammarco MA; Municchi G; Toni S; Lenzi L; Verrotti A; de Martino M
    Nutrients; 2017 May; 9(5):. PubMed ID: 28531113
    [No Abstract]   [Full Text] [Related]  

  • 7. THE IMPACT OF THE DEGREE OF OBESITY ON METABOLIC PARAMETERS IN CHILDREN AND ADOLESCENTS.
    Tskhvedadze N; Giorgadze E; Janjgava S
    Georgian Med News; 2018 Dec; (285):51-56. PubMed ID: 30702070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin as a biomarker of clinical manifestation of metabolic syndrome.
    Tajtákova M; Petrásova D; Petrovicová J; Pytliak M; Semanová Z
    Endocr Regul; 2006 Mar; 40(1):15-9. PubMed ID: 16964963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
    Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH
    Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of clinical and laboratory markers of cardiometabolic risk in overweight and obese children and adolescents.
    Palhares HM; da Silva AP; Resende DC; Pereira GA; Rodrigues V; Borges MF
    Clinics (Sao Paulo); 2017 Jan; 72(1):36-43. PubMed ID: 28226031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
    Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low insulin-like growth factor 1 is associated with low high-density lipoprotein cholesterol and metabolic syndrome in Chinese nondiabetic obese children and adolescents: a cross-sectional study.
    Liang S; Hu Y; Liu C; Qi J; Li G
    Lipids Health Dis; 2016 Jun; 15():112. PubMed ID: 27343122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
    Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
    Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UCP1 -3826 AG+GG genotypes, adiponectin, and leptin/adiponectin ratio in severe obesity.
    Labruna G; Pasanisi F; Nardelli C; Tarantino G; Vitale DF; Bracale R; Finelli C; Genua MP; Contaldo F; Sacchetti L
    J Endocrinol Invest; 2009 Jun; 32(6):525-9. PubMed ID: 19474520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
    Shalitin S; Abrahami M; Lilos P; Phillip M
    Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome.
    Rautio K; Tapanainen JS; Ruokonen A; Morin-Papunen LC
    Eur J Endocrinol; 2005 Feb; 152(2):269-75. PubMed ID: 15745936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebo-controlled clinical trial.
    Atabek ME; Pirgon O
    J Pediatr Endocrinol Metab; 2008 Apr; 21(4):339-48. PubMed ID: 18556965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
    Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
    Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.